NDC 0069-5471-01 - CEREBYX
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0069-5471
- Requested NDC
- 0069-5471-01
- Package NDCs from labels
- 0069-5471-01, 0069-5471-02
- Manufacturer
- Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Pharmacia & Upjohn Company LLC
- Effective date
- 2025-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEREBYX - Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Pharmacia & Upjohn Company LLC | Pfizer Laboratories Div Pfizer Inc | Pfizer Inc | Pharmacia & Upjohn Company LLC | 2025-05-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0069-5471-01 | CEREBYX | 2 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 2 | 29 | |
| 0069-5471-02 | CEREBYX | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 29 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0069-5471-01 | ML - Milliliter | 0069-5471 | 4f96b53c-0699-4015-9c79-43531269d2f2 | 1 | 2015-02-02 |
| 0069-5471-02 | ML - Milliliter | 0069-5471 | 8fd7951c-f98a-4710-be02-dcdf7dd9650b | 1 | 2015-02-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FOSPHENYTOIN SODIUM | ACTIVE INGREDIENT | 7VLR55452Z | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| PHENYTOIN | ACTIVE MOIETY | 6158TKW0C5 | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| TROMETHAMINE | INACTIVE INGREDIENT | 023C2WHX2V | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | CEREBYX (FOSPHENYTOIN SODIUM) INJECTION, SOLUTION [PFIZER LABORATORIES] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bio Rock Water | ROCK WATER | BioActive Nutritional, Inc. | 178bd16d-0d4f-49d8-866b-8ab3a3c6889d | 2018-07-30 | Warnings | 059QF0KO0R |
| Fosphenytoin Sodium | FOSPHENYTOIN SODIUM | West-Ward Pharmaceuticals Corp | c92df63b-5140-4213-8d43-8327ff6230b7 | 2018-01-04 | Boxed warning, Warnings, Adverse reactions | 1670200 1670195 7VLR55452Z |
| Sterile Water | WATER | Baxter Healthcare Corporation | ef3e79c5-3f58-4b36-a296-64b7d9a651c1 | 2017-10-17 | Warnings, Adverse reactions | 059QF0KO0R |
| Eye Wash | WATER | CVS Pharmacy | 049cee29-7ec2-4d5b-8308-f522acde43a7 | 2017-03-29 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.